,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,6.77386113600444e-06,0.00556811385379565
2,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,2.3055074126447e-05,0.00947563546596972
3,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.000472784378102293,0.129542919600028
4,WP_IRON_METABOLISM_DISORDERS,10,Down,0.00091381658941656,0.187789309125103
5,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Down,0.00156873878886431,0.25267907420299
6,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.00184437280440139,0.25267907420299
7,WP_GLUCOCORTICOID_BIOSYNTHESIS,5,Down,0.0021836854881114,0.256427067318225
8,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.00510106725367864,0.524134660315481
9,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.00575711265411217,0.525816289075578
10,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.00672821215065687,0.542581024432662
11,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.00762228501551115,0.542581024432662
12,WP_ONECARBON_METABOLISM,22,Down,0.0079208908676301,0.542581024432662
13,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.0093722980572164,0.568436691494631
14,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.00975358471247938,0.568436691494631
15,WP_MINERALOCORTICOID_BIOSYNTHESIS,4,Down,0.0106434901590694,0.568436691494631
16,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.011064461148314,0.568436691494631
17,WP_PROTEASOME_DEGRADATION,57,Down,0.0119839216822234,0.57007980129046
18,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.0133884563570688,0.57007980129046
19,WP_IDO_METABOLIC_PATHWAY,7,Up,0.0137327926579753,0.57007980129046
20,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0144973424194088,0.57007980129046
21,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.0145640825147198,0.57007980129046
22,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Down,0.0162626819716468,0.607632935486075
23,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Down,0.020327586397184,0.650195330666357
24,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,0.0206349053370338,0.650195330666357
25,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.0212455578330762,0.650195330666357
26,WP_MONOAMINE_GPCRS,3,Up,0.021862186333456,0.650195330666357
27,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.0230211022266242,0.650195330666357
28,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.0234221795859664,0.650195330666357
29,WP_MALE_INFERTILITY,66,Down,0.0237976663022391,0.650195330666357
30,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.0261202270589395,0.650195330666357
31,WP_NRF2_PATHWAY,67,Down,0.0264424671033781,0.650195330666357
32,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.0266070197712693,0.650195330666357
33,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Down,0.0266077656191231,0.650195330666357
34,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.0273601513089581,0.650195330666357
35,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.0276847160259398,0.650195330666357
36,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.0301839960749695,0.657098199788549
37,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Down,0.0311891296087391,0.657098199788549
38,WP_FERROPTOSIS,50,Down,0.0312949114770924,0.657098199788549
39,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.0319667350041915,0.657098199788549
40,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.0327332293280395,0.657098199788549
41,WP_MEVALONATE_PATHWAY,7,Up,0.0327749710356819,0.657098199788549
42,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.0346369293316995,0.664378815354624
43,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.0350825121387016,0.664378815354624
44,WP_CREATINE_PATHWAY,2,Up,0.0355628562963546,0.664378815354624
45,WP_ZINC_HOMEOSTASIS,21,Down,0.0371276887281372,0.67819911410064
46,WP_BENZOAPYRENE_METABOLISM,5,Down,0.0397317831473146,0.709989690154186
47,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Down,0.0433473199777866,0.758116957909375
48,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.046798274181512,0.778808642917138
49,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.0468463883764938,0.778808642917138
50,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.0490017441379422,0.778808642917138
51,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.0511287202088939,0.778808642917138
52,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.0515284986338782,0.778808642917138
53,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.0523367936123365,0.778808642917138
54,WP_KLEEFSTRA_SYNDROME,24,Up,0.0531561353957029,0.778808642917138
55,WP_CAMKK2_PATHWAY,29,Down,0.0539390904881401,0.778808642917138
56,WP_PPARALPHA_PATHWAY,15,Down,0.0541005030233264,0.778808642917138
57,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Up,0.0544225807765966,0.778808642917138
58,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Up,0.0549524346583869,0.778808642917138
59,WP_ID_SIGNALING,12,Down,0.0610526432760616,0.846216896505613
60,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.0656988528074726,0.846216896505613
61,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.0659455221124031,0.846216896505613
62,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Down,0.0678915867786039,0.846216896505613
63,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Up,0.0679823025087791,0.846216896505613
64,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Down,0.0680180174464502,0.846216896505613
65,WP_DOPAMINE_METABOLISM,7,Down,0.0708586583536659,0.846216896505613
66,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.0714569891575983,0.846216896505613
67,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.0720662618222043,0.846216896505613
68,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.0721767330245494,0.846216896505613
69,WP_TP53_NETWORK,16,Down,0.0724362224418647,0.846216896505613
70,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.07252536486246,0.846216896505613
71,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.0730917270704361,0.846216896505613
72,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.0775005443255408,0.878998569337355
73,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.0780619167416386,0.878998569337355
74,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,26,Up,0.0819222626355676,0.881239669616453
75,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,20,Down,0.0824492246331435,0.881239669616453
76,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.0825359687134771,0.881239669616453
77,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.0825492147937553,0.881239669616453
78,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.0847248970589072,0.881732253237803
79,WP_PPAR_SIGNALING,39,Down,0.0855395439161016,0.881732253237803
80,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.0860995971112792,0.881732253237803
81,WP_ALLOGRAFT_REJECTION,48,Down,0.0883318544983475,0.881732253237803
82,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.0885132457484072,0.881732253237803
83,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.0890313589035738,0.881732253237803
84,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Up,0.0916407983995817,0.89677067005305
85,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.0935498199118024,0.897942775705567
86,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.0948409235320668,0.897942775705567
87,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Up,0.0958992936309522,0.897942775705567
88,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.0961301268395254,0.897942775705567
89,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.0993939594544809,0.917998142377341
90,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.102883689923572,0.93967103463529
91,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.108099053532353,0.942222904673296
92,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Up,0.108142222833162,0.942222904673296
93,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.110317944303292,0.942222904673296
94,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Up,0.111769239885796,0.942222904673296
95,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.111782863831528,0.942222904673296
96,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.113103918223155,0.942222904673296
97,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.114641205539346,0.942222904673296
98,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.118673361626136,0.942222904673296
99,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Up,0.11921199510854,0.942222904673296
100,WP_TYPE_II_INTERFERON_SIGNALING,29,Down,0.121742404734097,0.942222904673296
101,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.125582795351609,0.942222904673296
102,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.126356211990982,0.942222904673296
103,WP_TRANSLATION_FACTORS,49,Up,0.126665300995697,0.942222904673296
104,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.126843483217434,0.942222904673296
105,WP_NEPHROGENESIS,4,Up,0.127067681092201,0.942222904673296
106,WP_SPINAL_CORD_INJURY,63,Down,0.130424685126981,0.942222904673296
107,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.131111967553292,0.942222904673296
108,WP_SMALL_LIGAND_GPCRS,7,Down,0.134760246449144,0.942222904673296
109,WP_SPINA_BIFIDA,10,Down,0.135016863478827,0.942222904673296
110,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.137213883745471,0.942222904673296
111,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.137511313096336,0.942222904673296
112,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.138180814298197,0.942222904673296
113,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.139464709604615,0.942222904673296
114,WP_FOLATE_METABOLISM,36,Down,0.143708217462419,0.942222904673296
115,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.144982938024723,0.942222904673296
116,WP_ENERGY_METABOLISM,41,Up,0.145510965681866,0.942222904673296
117,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.147098176872652,0.942222904673296
118,WP_DRAVET_SYNDROME,12,Up,0.148446868432288,0.942222904673296
119,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Down,0.148666528852099,0.942222904673296
120,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.149188426531537,0.942222904673296
121,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.150320802737253,0.942222904673296
122,WP_FOXP3_IN_COVID19,9,Down,0.151121844956123,0.942222904673296
123,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.151514710437681,0.942222904673296
124,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Up,0.155753974853426,0.942222904673296
125,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Up,0.156040612314654,0.942222904673296
126,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.156617174168587,0.942222904673296
127,WP_HEME_BIOSYNTHESIS,8,Down,0.156617174168587,0.942222904673296
128,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.158745239633297,0.942222904673296
129,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.160177946612214,0.942222904673296
130,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.161804993643691,0.942222904673296
131,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.162046788433694,0.942222904673296
132,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.162351936913895,0.942222904673296
133,WP_VITAMIN_B12_METABOLISM,23,Down,0.162719530354489,0.942222904673296
134,WP_CORI_CYCLE,11,Down,0.166177399643286,0.942222904673296
135,WP_RETINOL_METABOLISM,6,Up,0.168955126479905,0.942222904673296
136,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.169353639531967,0.942222904673296
137,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.169657441375533,0.942222904673296
138,WP_INFLAMMATORY_RESPONSE_PATHWAY,12,Down,0.17083534672306,0.942222904673296
139,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.17243436826372,0.942222904673296
140,WP_NUCLEOTIDE_GPCRS,5,Up,0.172680456534276,0.942222904673296
141,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.173447511518452,0.942222904673296
142,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.173774245003674,0.942222904673296
143,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.175163288733084,0.942222904673296
144,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.175664899090278,0.942222904673296
145,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.176710451176949,0.942222904673296
146,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Up,0.177326949140399,0.942222904673296
147,WP_BASE_EXCISION_REPAIR,29,Down,0.178791931725459,0.942222904673296
148,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Up,0.17923882479265,0.942222904673296
149,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Up,0.180273639053232,0.942222904673296
150,WP_IRINOTECAN_PATHWAY,5,Down,0.18077227614342,0.942222904673296
151,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.180808787681575,0.942222904673296
152,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Up,0.181028563078323,0.942222904673296
153,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.182312504166696,0.942222904673296
154,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Up,0.182784365611597,0.942222904673296
155,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.183718946515417,0.942222904673296
156,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.18385095834875,0.942222904673296
157,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.185512318352688,0.942222904673296
158,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.185943588984132,0.942222904673296
159,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Up,0.186378002039338,0.942222904673296
160,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.188394432377099,0.942222904673296
161,WP_AEROBIC_GLYCOLYSIS,10,Down,0.190748692224004,0.942222904673296
162,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.190748692224004,0.942222904673296
163,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.193539745668821,0.942222904673296
164,WP_WNT_SIGNALING_AND_PLURIPOTENCY,59,Up,0.193576917611155,0.942222904673296
165,WP_SERINE_METABOLISM,5,Down,0.194082420791993,0.942222904673296
166,WP_PREIMPLANTATION_EMBRYO,20,Down,0.194303361464135,0.942222904673296
167,WP_IL4_SIGNALING,50,Up,0.195089901556712,0.942222904673296
168,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.198080647952723,0.942222904673296
169,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.199326870237106,0.942222904673296
170,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.200055120416035,0.942222904673296
171,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.200084864292298,0.942222904673296
172,WP_METASTATIC_BRAIN_TUMOR,5,Down,0.200147592119007,0.942222904673296
173,WP_BENZENE_METABOLISM,3,Down,0.200396778330421,0.942222904673296
174,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.20089505715213,0.942222904673296
175,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Down,0.200949056395298,0.942222904673296
176,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.208858005360906,0.942222904673296
177,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.208942942278936,0.942222904673296
178,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.211098269744985,0.942222904673296
179,WP_AXON_GUIDANCE,35,Down,0.213639662958562,0.942222904673296
180,WP_HUNGER_AND_SATIETY,2,Up,0.216950886609882,0.942222904673296
181,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.217570883141955,0.942222904673296
182,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.221665396607738,0.942222904673296
183,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,130,Down,0.224505061989595,0.942222904673296
184,WP_CHOLESTASIS,9,Up,0.224916032803406,0.942222904673296
185,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.230607331598351,0.942222904673296
186,WP_G13_SIGNALING,29,Up,0.231074374664377,0.942222904673296
187,WP_OVARIAN_INFERTILITY,20,Up,0.234306542794936,0.942222904673296
188,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.234931698843629,0.942222904673296
189,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.23732471374755,0.942222904673296
190,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.238703797851689,0.942222904673296
191,WP_SEROTONIN_AND_ANXIETY,7,Up,0.242530800629114,0.942222904673296
192,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.245766364014667,0.942222904673296
193,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.24634275923979,0.942222904673296
194,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Down,0.247320731753447,0.942222904673296
195,WP_SPHINGOLIPID_PATHWAY,19,Up,0.248123923450839,0.942222904673296
196,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.248760214194258,0.942222904673296
197,WP_COMPLEMENT_ACTIVATION,11,Down,0.251859781410976,0.942222904673296
198,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.254411651852296,0.942222904673296
199,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.255117323730666,0.942222904673296
200,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Up,0.257366705865788,0.942222904673296
201,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.257520779099857,0.942222904673296
202,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.259080232455578,0.942222904673296
203,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.26044574134009,0.942222904673296
204,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Down,0.264503188336639,0.942222904673296
205,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Up,0.264701637478515,0.942222904673296
206,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Down,0.265494654902177,0.942222904673296
207,WP_IL1_SIGNALING,51,Up,0.26745932476473,0.942222904673296
208,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.268786767624629,0.942222904673296
209,WP_ATR_SIGNALING,10,Down,0.269053249071507,0.942222904673296
210,WP_NAD_METABOLISM,11,Up,0.269694181811155,0.942222904673296
211,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.26972364415419,0.942222904673296
212,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.269994330704715,0.942222904673296
213,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.27053236284061,0.942222904673296
214,WP_HEART_DEVELOPMENT,16,Down,0.271228531273581,0.942222904673296
215,WP_JOUBERT_SYNDROME,71,Up,0.272218328880025,0.942222904673296
216,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.272284411992482,0.942222904673296
217,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.273138930939219,0.942222904673296
218,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.273799565816555,0.942222904673296
219,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.275358593147952,0.942222904673296
220,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,42,Up,0.276070727169118,0.942222904673296
221,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.276514607324476,0.942222904673296
222,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.27985647741271,0.942222904673296
223,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Up,0.280324538014947,0.942222904673296
224,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.280387807403227,0.942222904673296
225,WP_VALPROIC_ACID_PATHWAY,8,Up,0.280692505361471,0.942222904673296
226,WP_ASPIRIN_AND_MIRNAS,8,Up,0.281965419318302,0.942222904673296
227,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Down,0.282286228453411,0.942222904673296
228,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Up,0.285757563341981,0.942222904673296
229,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.286931345618618,0.942222904673296
230,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Down,0.287955861746427,0.942222904673296
231,WP_IL18_SIGNALING,186,Down,0.290525180509232,0.942222904673296
232,WP_THERMOGENESIS,72,Up,0.290942222814546,0.942222904673296
233,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.293925045198946,0.942222904673296
234,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.296256782445926,0.942222904673296
235,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.297380767427035,0.942222904673296
236,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.298344962127951,0.942222904673296
237,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.299462250324988,0.942222904673296
238,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.300403722232209,0.942222904673296
239,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.302607115185691,0.942222904673296
240,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.303820366076876,0.942222904673296
241,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.304004582745817,0.942222904673296
242,WP_CHOLESTEROL_METABOLISM,52,Up,0.304384741730577,0.942222904673296
243,WP_TAMOXIFEN_METABOLISM,2,Down,0.305010763317229,0.942222904673296
244,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.306415626980746,0.942222904673296
245,WP_WNT_SIGNALING_WP428,58,Up,0.3065523556812,0.942222904673296
246,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.308397039155783,0.942222904673296
247,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.308748043660048,0.942222904673296
248,WP_INTEGRATED_CANCER_PATHWAY,39,Down,0.309790278978355,0.942222904673296
249,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.31316943700935,0.942222904673296
250,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.31616218300096,0.942222904673296
251,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.317006290564691,0.942222904673296
252,WP_DNA_DAMAGE_RESPONSE,57,Down,0.318263163490183,0.942222904673296
253,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Down,0.32154295179197,0.942222904673296
254,WP_GASTRIC_CANCER_NETWORK_2,24,Down,0.322033802979184,0.942222904673296
255,WP_P38_MAPK_SIGNALING,31,Up,0.322157088105054,0.942222904673296
256,WP_EGFEGFR_SIGNALING,136,Down,0.322665105720588,0.942222904673296
257,WP_ADIPOGENESIS,84,Down,0.322747003606851,0.942222904673296
258,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.323368190924859,0.942222904673296
259,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.323925596982185,0.942222904673296
260,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.324490573537526,0.942222904673296
261,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.32852175564645,0.942222904673296
262,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.32934985101734,0.942222904673296
263,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.32934985101734,0.942222904673296
264,WP_PROSTAGLANDIN_SIGNALING,20,Up,0.332202480523187,0.942222904673296
265,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.332807326166386,0.942222904673296
266,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.333804935540551,0.942222904673296
267,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Up,0.335127074739907,0.942222904673296
268,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.335651592365422,0.942222904673296
269,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.335834272834906,0.942222904673296
270,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Up,0.336663608343848,0.942222904673296
271,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.336789883344407,0.942222904673296
272,WP_TRANSSULFURATION_PATHWAY,8,Up,0.336939435930837,0.942222904673296
273,WP_IL26_SIGNALING,31,Down,0.337450516807364,0.942222904673296
274,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.337656997975446,0.942222904673296
275,WP_GPCRS_OTHER,11,Down,0.339349880110971,0.942222904673296
276,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.340209075993335,0.942222904673296
277,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.340798253462911,0.942222904673296
278,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.341032757157384,0.942222904673296
279,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.341100582216857,0.942222904673296
280,WP_PRION_DISEASE_PATHWAY,28,Up,0.34129543103557,0.942222904673296
281,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.342460346665511,0.942222904673296
282,WP_OSTEOCLAST_SIGNALING,8,Down,0.343315554961378,0.942222904673296
283,WP_5Q35_COPY_NUMBER_VARIATION,75,Down,0.343662474843836,0.942222904673296
284,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.34453374506555,0.942222904673296
285,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.345223445895436,0.942222904673296
286,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.345293753121165,0.942222904673296
287,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.346190305525494,0.942222904673296
288,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.346304907709733,0.942222904673296
289,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,86,Down,0.34632834463487,0.942222904673296
290,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.347217412655019,0.942222904673296
291,WP_NEURAL_CREST_DIFFERENTIATION,37,Down,0.34735702374891,0.942222904673296
292,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.349522812368252,0.942222904673296
293,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.350327619432455,0.942222904673296
294,WP_IL7_SIGNALING,23,Down,0.350420026479199,0.942222904673296
295,WP_NEPHROTIC_SYNDROME,27,Down,0.350483283119691,0.942222904673296
296,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Down,0.354644095303454,0.942222904673296
297,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.354698133479692,0.942222904673296
298,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.360196353324776,0.942222904673296
299,WP_RETT_SYNDROME,31,Up,0.361980968788784,0.942222904673296
300,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Up,0.362422557520785,0.942222904673296
301,WP_SYNAPTIC_VESICLE_PATHWAY,19,Down,0.362436025646419,0.942222904673296
302,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.362880778874454,0.942222904673296
303,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.363296361517395,0.942222904673296
304,WP_IL11_SIGNALING,40,Down,0.363603704975264,0.942222904673296
305,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Down,0.363883183114983,0.942222904673296
306,WP_FOXA2_PATHWAY,9,Down,0.364971532405242,0.942222904673296
307,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Up,0.364987437146101,0.942222904673296
308,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.365515326366601,0.942222904673296
309,WP_GPR40_PATHWAY,7,Down,0.366671499765903,0.942222904673296
310,WP_NEOVASCULARIZATION_PROCESSES,20,Down,0.367486722690482,0.942222904673296
311,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.368183661664728,0.942222904673296
312,WP_TRYPTOPHAN_METABOLISM,18,Up,0.369995602918819,0.942222904673296
313,WP_IL17_SIGNALING,25,Down,0.370201423623045,0.942222904673296
314,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.37158586185168,0.942222904673296
315,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.372335688577012,0.942222904673296
316,WP_SLEEP_REGULATION,10,Down,0.373420208164551,0.942222904673296
317,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Down,0.374208954330932,0.942222904673296
318,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.374998394958013,0.942222904673296
319,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.376903715957799,0.942222904673296
320,WP_LUNG_FIBROSIS,30,Up,0.378276586869952,0.942222904673296
321,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Up,0.378470370007538,0.942222904673296
322,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.378547595953699,0.942222904673296
323,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.378981009766296,0.942222904673296
324,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.379441133527515,0.942222904673296
325,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.380038303906214,0.942222904673296
326,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.381321733616098,0.942222904673296
327,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Down,0.384533947917356,0.942222904673296
328,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Down,0.384799399336225,0.942222904673296
329,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.385807660921163,0.942222904673296
330,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.386625579579103,0.942222904673296
331,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.386781027035405,0.942222904673296
332,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Up,0.38718782407502,0.942222904673296
333,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.387619607213847,0.942222904673296
334,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.388039794488167,0.942222904673296
335,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.390081261947231,0.942222904673296
336,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.390520882470155,0.942222904673296
337,WP_RANKLRANK_SIGNALING,47,Down,0.390627784595038,0.942222904673296
338,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.391275671346141,0.942222904673296
339,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.391877732072985,0.942222904673296
340,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.391889736457598,0.942222904673296
341,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.393760339376529,0.942222904673296
342,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.394436471502585,0.942222904673296
343,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.396227120565054,0.942222904673296
344,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.396359191753217,0.942222904673296
345,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Up,0.399181319482045,0.942222904673296
346,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Up,0.399865962887582,0.942222904673296
347,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.400061234177855,0.942222904673296
348,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Up,0.402754472553983,0.942222904673296
349,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.404430544919045,0.942222904673296
350,WP_TYPE_II_DIABETES_MELLITUS,13,Down,0.40446966655233,0.942222904673296
351,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.405270902929303,0.942222904673296
352,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.405790396884868,0.942222904673296
353,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Up,0.406886482988766,0.942222904673296
354,WP_RAS_SIGNALING,113,Down,0.408373561457705,0.942222904673296
355,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.408625072865711,0.942222904673296
356,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Up,0.409882703934182,0.942222904673296
357,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.411666628876203,0.942222904673296
358,WP_CILIOPATHIES,125,Up,0.412596076801536,0.942222904673296
359,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Down,0.413649531929703,0.942222904673296
360,WP_FRAGILE_X_SYNDROME,83,Up,0.413771651076475,0.942222904673296
361,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Down,0.416446486834262,0.942222904673296
362,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.417635081486466,0.942222904673296
363,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.418115473856598,0.942222904673296
364,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.419862595180863,0.942222904673296
365,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.42315196368298,0.942222904673296
366,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.424222081815948,0.942222904673296
367,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Up,0.424991523621354,0.942222904673296
368,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.425157935894333,0.942222904673296
369,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.425629332364544,0.942222904673296
370,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.42581356848169,0.942222904673296
371,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.426073524348749,0.942222904673296
372,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Down,0.426632059325673,0.942222904673296
373,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.427553702485571,0.942222904673296
374,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.431910800511282,0.943680832221688
375,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.432284657724404,0.943680832221688
376,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.432661951003809,0.943680832221688
377,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.432807388987319,0.943680832221688
378,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.437539280727105,0.949096042988736
379,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,0.439981901929912,0.949096042988736
380,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,36,Down,0.444576939792505,0.949096042988736
381,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Up,0.445079019273571,0.949096042988736
382,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.445138595535195,0.949096042988736
383,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,169,Down,0.446980530852757,0.949096042988736
384,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.44745097264333,0.949096042988736
385,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Down,0.447562971149819,0.949096042988736
386,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.44800244452847,0.949096042988736
387,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Down,0.448030556615697,0.949096042988736
388,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.449707586473469,0.949096042988736
389,WP_VITAMIN_D_METABOLISM,6,Up,0.450874434136545,0.949096042988736
390,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.451879002115083,0.949096042988736
391,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.451911920624013,0.949096042988736
392,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.452610278408254,0.949096042988736
393,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.457785378371319,0.95112255722555
394,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,61,Up,0.460283595028779,0.95112255722555
395,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.460447082608889,0.95112255722555
396,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.460458099994961,0.95112255722555
397,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.461697369164378,0.95112255722555
398,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.46184121012105,0.95112255722555
399,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.463667338370078,0.95112255722555
400,WP_MAPK_SIGNALING,156,Down,0.464235114095092,0.95112255722555
401,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.464637617824783,0.95112255722555
402,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.465663277991797,0.95112255722555
403,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.469059642726362,0.95112255722555
404,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.470163693406517,0.95112255722555
405,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,43,Down,0.470323480015177,0.95112255722555
406,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.472123544083837,0.95112255722555
407,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Up,0.472613259573874,0.95112255722555
408,WP_BARDETBIEDL_SYNDROME,65,Up,0.472807782047058,0.95112255722555
409,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Up,0.475755641392667,0.95112255722555
410,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.476621160694882,0.95112255722555
411,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Down,0.477146439973947,0.95112255722555
412,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.477471476455332,0.95112255722555
413,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.48161201499322,0.95112255722555
414,WP_METHYLATION_PATHWAYS,5,Down,0.481759079018176,0.95112255722555
415,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.4842297656089,0.95112255722555
416,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.48459854773062,0.95112255722555
417,WP_SILDENAFIL_TREATMENT,10,Down,0.485083693962884,0.95112255722555
418,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.48639789712348,0.95112255722555
419,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Up,0.487782679226003,0.95112255722555
420,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.488142053411593,0.95112255722555
421,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.488142053411593,0.95112255722555
422,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.492808760097788,0.95112255722555
423,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.493246521096662,0.95112255722555
424,WP_SMALL_CELL_LUNG_CANCER,67,Down,0.496107119047067,0.95112255722555
425,WP_IL3_SIGNALING,46,Up,0.496622503646745,0.95112255722555
426,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.496845238776205,0.95112255722555
427,WP_MELANOMA,52,Down,0.497284973804508,0.95112255722555
428,WP_OREXIN_RECEPTOR_PATHWAY,117,Down,0.497567996909632,0.95112255722555
429,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.497940100427279,0.95112255722555
430,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.498336663355935,0.95112255722555
431,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Down,0.498702946671791,0.95112255722555
432,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.501645497476986,0.954519904921487
433,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.502993769998433,0.954875009096333
434,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.504413573949033,0.955363958032499
435,WP_LEPTIN_SIGNALING,69,Up,0.507641709714234,0.956390446322692
436,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.507871598999607,0.956390446322692
437,WP_TNFALPHA_SIGNALING,82,Up,0.508446015867417,0.956390446322692
438,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.511878861565045,0.960649370334399
439,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.516431421184544,0.966985485680399
440,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.518333892560534,0.968341953828997
441,WP_CANCER_PATHWAYS,295,Down,0.523748765712009,0.975937870469455
442,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.52477437803832,0.975937870469455
443,WP_ERBB_SIGNALING,67,Down,0.528312031356621,0.977773465504261
444,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.528949090597913,0.977773465504261
445,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,6,Up,0.529778344499429,0.977773465504261
446,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.532275220023005,0.977773465504261
447,WP_PROLACTIN_SIGNALING,68,Down,0.5355758758047,0.977773465504261
448,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Up,0.536205323251088,0.977773465504261
449,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.536443116674674,0.977773465504261
450,WP_ESTROGEN_SIGNALING,21,Up,0.537347321664971,0.977773465504261
451,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.538140883646713,0.977773465504261
452,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Down,0.538689540277136,0.977773465504261
453,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.539676803659601,0.977773465504261
454,WP_GASTRIC_CANCER_NETWORK_1,15,Down,0.540035466349069,0.977773465504261
455,WP_ECTODERM_DIFFERENTIATION,74,Up,0.544095990352647,0.980126659324017
456,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.544642319530168,0.980126659324017
457,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.54512268922524,0.980126659324017
458,WP_AGERAGE_PATHWAY,54,Down,0.546104635000486,0.980126659324017
459,WP_NUCLEAR_RECEPTORS,20,Down,0.55005061422777,0.980299785517526
460,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.550390756280758,0.980299785517526
461,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.553218339481788,0.980299785517526
462,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Down,0.556221580382711,0.980299785517526
463,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.559722629257605,0.980299785517526
464,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Down,0.560645087133,0.980299785517526
465,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.561620498968916,0.980299785517526
466,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Up,0.562071478600275,0.980299785517526
467,WP_CCL18_SIGNALING,20,Down,0.563544338905598,0.980299785517526
468,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Up,0.563556022604897,0.980299785517526
469,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.565154908954296,0.980299785517526
470,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Up,0.568043437412554,0.980299785517526
471,WP_COPPER_HOMEOSTASIS,39,Down,0.568177769484056,0.980299785517526
472,WP_OPIOID_RECEPTOR_PATHWAYS,24,Down,0.568358449341754,0.980299785517526
473,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.569308122226091,0.980299785517526
474,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.570582556741599,0.980299785517526
475,WP_MEASLES_VIRUS_INFECTION,98,Up,0.571550924493389,0.980299785517526
476,WP_ALPHA_6_BETA_4_SIGNALING,25,Up,0.573082083733696,0.980299785517526
477,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.573559285599105,0.980299785517526
478,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.57387529630894,0.980299785517526
479,WP_ARYLAMINE_METABOLISM,1,Down,0.574724672295437,0.980299785517526
480,WP_PYRIMIDINE_METABOLISM,71,Down,0.575901910683267,0.980299785517526
481,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.577188994237737,0.980299785517526
482,WP_WNT_SIGNALING_WP363,37,Up,0.578332967132068,0.980299785517526
483,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.580865401176809,0.980299785517526
484,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.582563346394667,0.980299785517526
485,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.585548363836688,0.980299785517526
486,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.58563426061942,0.980299785517526
487,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.585876143052602,0.980299785517526
488,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.587724747332031,0.980299785517526
489,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.589844191173008,0.980299785517526
490,WP_VITAMIN_B12_DISORDERS,9,Up,0.590579669901932,0.980299785517526
491,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Up,0.596356539237868,0.980299785517526
492,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Down,0.596687546956699,0.980299785517526
493,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.600149912098427,0.980299785517526
494,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.601263927882657,0.980299785517526
495,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.602829783760241,0.980299785517526
496,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.602865535452122,0.980299785517526
497,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Down,0.603560634594644,0.980299785517526
498,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.603629464135155,0.980299785517526
499,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,70,Down,0.607093367205156,0.980299785517526
500,WP_BLADDER_CANCER,28,Down,0.607387400817586,0.980299785517526
501,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.608948418620193,0.980299785517526
502,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.614027613799556,0.980299785517526
503,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.618158598995183,0.980299785517526
504,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.623404852002261,0.980299785517526
505,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.623439312439351,0.980299785517526
506,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.62418565887851,0.980299785517526
507,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.625889631374631,0.980299785517526
508,WP_IL9_SIGNALING,15,Down,0.626752936978687,0.980299785517526
509,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.627104802015839,0.980299785517526
510,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.628482502749122,0.980299785517526
511,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Up,0.629324898776388,0.980299785517526
512,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.631284193364272,0.980299785517526
513,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.633568922500932,0.980299785517526
514,WP_G_PROTEIN_SIGNALING,61,Down,0.635700565348831,0.980299785517526
515,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.638019816290749,0.980299785517526
516,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.638333039524924,0.980299785517526
517,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Up,0.638421279866822,0.980299785517526
518,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Up,0.638556735914591,0.980299785517526
519,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.641478327112971,0.980299785517526
520,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.641732733075936,0.980299785517526
521,WP_OSTEOBLAST_SIGNALING,2,Down,0.641747544732159,0.980299785517526
522,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.642257891701923,0.980299785517526
523,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.646162303777468,0.980299785517526
524,WP_NONSMALL_CELL_LUNG_CANCER,57,Up,0.646905667614649,0.980299785517526
525,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.647961048115857,0.980299785517526
526,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.64994422037788,0.980299785517526
527,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.65443155063219,0.980299785517526
528,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.655708197890842,0.980299785517526
529,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.655749121841594,0.980299785517526
530,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.655884223185243,0.980299785517526
531,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Up,0.656603731037361,0.980299785517526
532,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Down,0.657554262047067,0.980299785517526
533,WP_ANGIOGENESIS,12,Down,0.660370701354875,0.980299785517526
534,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.66228208244372,0.980299785517526
535,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.662835784084328,0.980299785517526
536,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Down,0.662880224499062,0.980299785517526
537,WP_MAPK_CASCADE,30,Up,0.664977369084129,0.980299785517526
538,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.666581154213228,0.980299785517526
539,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.668291986087126,0.980299785517526
540,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.669489127713267,0.980299785517526
541,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.670070742135002,0.980299785517526
542,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.673669969380474,0.980299785517526
543,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.67510610971764,0.980299785517526
544,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.675402633858377,0.980299785517526
545,WP_TGFB_SMAD_SIGNALING,7,Up,0.676299239974783,0.980299785517526
546,WP_NEUROINFLAMMATION,10,Up,0.676367810540016,0.980299785517526
547,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,45,Down,0.678366261533978,0.980299785517526
548,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.678406933443894,0.980299785517526
549,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.678648940601164,0.980299785517526
550,WP_INSULIN_SIGNALING,129,Down,0.679516115890459,0.980299785517526
551,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.679662730013883,0.980299785517526
552,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.680236473573148,0.980299785517526
553,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Up,0.681212646128224,0.980299785517526
554,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.682126226759701,0.980299785517526
555,WP_KALLMANN_SYNDROME,11,Up,0.682220969457082,0.980299785517526
556,WP_NOTCH_SIGNALING_WP268,34,Up,0.683620753670875,0.980299785517526
557,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.684325407930286,0.980299785517526
558,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.684481296488362,0.980299785517526
559,WP_B_CELL_RECEPTOR_SIGNALING,84,Up,0.686694104975621,0.980299785517526
560,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.688427473398792,0.980299785517526
561,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.689277821707125,0.980299785517526
562,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.689348703135207,0.980299785517526
563,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.689418735097525,0.980299785517526
564,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.691304265695956,0.980299785517526
565,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Down,0.694630924093826,0.980299785517526
566,WP_ENDOTHELIN_PATHWAYS,11,Up,0.695710785280333,0.980299785517526
567,WP_NPHP1_DELETION_SYNDROME,10,Up,0.695995538719164,0.980299785517526
568,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.697964579263246,0.980299785517526
569,WP_NOTCH_SIGNALING_WP61,48,Down,0.698441692001468,0.980299785517526
570,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.699696473148393,0.980299785517526
571,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.700585799813016,0.980299785517526
572,WP_NRXN1_DELETION_SYNDROME,2,Up,0.701780469305557,0.980299785517526
573,WP_BDNFTRKB_SIGNALING,26,Down,0.701828495925313,0.980299785517526
574,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.702577110925854,0.980299785517526
575,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.703278354026612,0.980299785517526
576,WP_VEGFAVEGFR2_SIGNALING,333,Down,0.704226014407201,0.980299785517526
577,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Down,0.704321199396677,0.980299785517526
578,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.705339824951696,0.980299785517526
579,WP_TOLLLIKE_RECEPTOR_SIGNALING,78,Down,0.705679517204929,0.980299785517526
580,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.706059659760299,0.980299785517526
581,WP_MONOAMINE_TRANSPORT,11,Down,0.709886145165902,0.980299785517526
582,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Up,0.71064494822062,0.980299785517526
583,WP_EICOSANOID_SYNTHESIS,13,Up,0.714949966784683,0.980299785517526
584,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.717235111898434,0.980299785517526
585,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Up,0.717575043126851,0.980299785517526
586,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.72011962262007,0.980299785517526
587,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.7227622835914,0.980299785517526
588,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.723412584677782,0.980299785517526
589,WP_APOPTOSIS_MODULATION_AND_SIGNALING,75,Down,0.723447596968731,0.980299785517526
590,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.725219369399452,0.980299785517526
591,WP_CHEMOKINE_SIGNALING,107,Down,0.726165284962589,0.980299785517526
592,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.72632826925236,0.980299785517526
593,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.727327741171777,0.980299785517526
594,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.731460562254222,0.980299785517526
595,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.732189511639798,0.980299785517526
596,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.732445471562825,0.980299785517526
597,WP_MIRNA_BIOGENESIS,6,Down,0.732486611351198,0.980299785517526
598,WP_GASTRIN_SIGNALING,92,Down,0.73267421263683,0.980299785517526
599,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.732731812696672,0.980299785517526
600,WP_BREAST_CANCER_PATHWAY,84,Up,0.733003932814958,0.980299785517526
601,WP_PEPTIDE_GPCRS,13,Down,0.733250855016211,0.980299785517526
602,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.733363016732412,0.980299785517526
603,WP_CELL_CYCLE,90,Down,0.735136809390599,0.980299785517526
604,WP_GLUCURONIDATION,7,Down,0.736350457625891,0.980299785517526
605,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.737377344138194,0.980299785517526
606,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.740205007351564,0.980299785517526
607,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.740758686603756,0.980299785517526
608,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.740769763131747,0.980299785517526
609,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.741124539296242,0.980299785517526
610,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Up,0.742844855651301,0.980299785517526
611,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.743845618274794,0.980299785517526
612,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Up,0.744203323886553,0.980299785517526
613,WP_ENDODERM_DIFFERENTIATION,80,Up,0.745725482018073,0.980299785517526
614,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.746054229865989,0.980299785517526
615,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.74836836796825,0.980299785517526
616,WP_PURINERGIC_SIGNALING,14,Down,0.750264710458419,0.980299785517526
617,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Up,0.751802877689411,0.980299785517526
618,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.752195827965837,0.980299785517526
619,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.754478953780334,0.980299785517526
620,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.755482251255095,0.980299785517526
621,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.756237371610387,0.980299785517526
622,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.757109897183576,0.980299785517526
623,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Down,0.75789146763548,0.980299785517526
624,WP_PLEURAL_MESOTHELIOMA,245,Up,0.759545029454495,0.980299785517526
625,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Up,0.76135945607828,0.980299785517526
626,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.761822787361229,0.980299785517526
627,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.761923255613854,0.980299785517526
628,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.76223707763834,0.980299785517526
629,WP_HEPATITIS_B_INFECTION,116,Up,0.762316915772999,0.980299785517526
630,WP_AMINO_ACID_METABOLISM,58,Up,0.763707032634348,0.980299785517526
631,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,19,Up,0.764963613563063,0.980299785517526
632,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.765576308956524,0.980299785517526
633,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Up,0.768254187107564,0.980299785517526
634,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Up,0.769674994569094,0.980299785517526
635,WP_CELLULAR_PROTEOSTASIS,6,Down,0.771232320157073,0.980299785517526
636,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Down,0.771490829347906,0.980299785517526
637,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.771824776076115,0.980299785517526
638,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Down,0.773126499486728,0.980299785517526
639,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.773186663930252,0.980299785517526
640,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.774640587445666,0.980299785517526
641,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.775361590915797,0.980299785517526
642,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.778890143996263,0.980299785517526
643,WP_HIPPOYAP_SIGNALING,16,Down,0.779016253857929,0.980299785517526
644,WP_ALSTROM_SYNDROME,27,Up,0.780087272996313,0.980299785517526
645,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.780618042257579,0.980299785517526
646,WP_NGLYCAN_BIOSYNTHESIS,51,Down,0.781854086881536,0.980299785517526
647,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.78311849196505,0.980299785517526
648,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.78332090447203,0.980299785517526
649,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.785218146946792,0.980299785517526
650,WP_PARKINSONS_DISEASE_PATHWAY,26,Down,0.786775094307946,0.980299785517526
651,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.78705907060673,0.980299785517526
652,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Up,0.788332051070959,0.980299785517526
653,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.789068498295079,0.980299785517526
654,WP_PURINE_METABOLISM,9,Up,0.790843287547834,0.980299785517526
655,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.791757902352956,0.980299785517526
656,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.793902840281345,0.980299785517526
657,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.793950791989821,0.980299785517526
658,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.795260196150316,0.980299785517526
659,WP_STEROID_BIOSYNTHESIS,2,Down,0.796447638881256,0.980299785517526
660,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.798800582186166,0.980299785517526
661,WP_FOCAL_ADHESION,114,Up,0.800377657442642,0.980299785517526
662,WP_AUTOPHAGY,27,Up,0.80293740198105,0.980299785517526
663,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.803242857840911,0.980299785517526
664,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.804592687008799,0.980299785517526
665,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.805625211928429,0.980299785517526
666,WP_NETRINUNC5B_SIGNALING,35,Up,0.807706113023743,0.980299785517526
667,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.808574910953087,0.980299785517526
668,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.81100549168562,0.980299785517526
669,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Down,0.812104987613669,0.980299785517526
670,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,125,Down,0.81275673555098,0.980299785517526
671,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,56,Down,0.813113947317192,0.980299785517526
672,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.813942073723896,0.980299785517526
673,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Up,0.814431838741139,0.980299785517526
674,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.815427852134792,0.980299785517526
675,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.815811895685825,0.980299785517526
676,WP_HIPPO_SIGNALING_REGULATION,44,Up,0.816796012100129,0.980299785517526
677,WP_PDGF_PATHWAY,35,Down,0.8170975451251,0.980299785517526
678,WP_KININKALLIKREIN_PATHWAY,2,Down,0.818342294316906,0.980299785517526
679,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Down,0.818402590246097,0.980299785517526
680,WP_MTHFR_DEFICIENCY,18,Up,0.818682704180543,0.980299785517526
681,WP_APOPTOSIS,70,Up,0.820531066866409,0.980299785517526
682,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,11,Down,0.824535188760608,0.980299785517526
683,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.825422081783391,0.980299785517526
684,WP_DNA_REPLICATION,35,Down,0.825638716612518,0.980299785517526
685,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.826103736837371,0.980299785517526
686,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Up,0.826878119562131,0.980299785517526
687,WP_GLIOBLASTOMA_SIGNALING,66,Up,0.827244883764837,0.980299785517526
688,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Up,0.82942694950365,0.980299785517526
689,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,54,Down,0.830289331394026,0.980299785517526
690,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.83073810165247,0.980299785517526
691,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.833295263707313,0.980299785517526
692,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.833298425841782,0.980299785517526
693,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.835180113286283,0.980299785517526
694,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.835825048358321,0.980299785517526
695,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.838074531227387,0.980299785517526
696,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Down,0.839822149736171,0.980299785517526
697,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.840760900942661,0.980299785517526
698,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.841156071360028,0.980299785517526
699,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Up,0.841381776282974,0.980299785517526
700,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.842127291514127,0.980299785517526
701,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.842127291514127,0.980299785517526
702,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.842771111885165,0.980299785517526
703,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.847505381678116,0.980299785517526
704,WP_CYTOSINE_METHYLATION,7,Up,0.847913003549066,0.980299785517526
705,WP_ALZHEIMERS_DISEASE,182,Down,0.848329153439062,0.980299785517526
706,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,182,Down,0.848329153439062,0.980299785517526
707,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.850380395879911,0.980299785517526
708,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.850808554974196,0.980299785517526
709,WP_IL5_SIGNALING,37,Up,0.851349138718727,0.980299785517526
710,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.851803292741391,0.980299785517526
711,WP_COMPLEMENT_SYSTEM,47,Down,0.853367911945829,0.980299785517526
712,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.854080959649866,0.980299785517526
713,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Up,0.854569290262061,0.980299785517526
714,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.855116345505839,0.980299785517526
715,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Up,0.855864642018494,0.980299785517526
716,WP_BURN_WOUND_HEALING,59,Up,0.855895685104697,0.980299785517526
717,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Down,0.856495262971199,0.980299785517526
718,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.858341944030197,0.980299785517526
719,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.859624995479031,0.980299785517526
720,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.861164112172139,0.980299785517526
721,WP_IL6_SIGNALING,38,Down,0.861943004233299,0.980299785517526
722,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.862953158847698,0.980299785517526
723,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.86299968784651,0.980299785517526
724,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Up,0.863427061696702,0.980299785517526
725,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Up,0.865872028388787,0.981719734255976
726,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Down,0.869561414166883,0.984544741660024
727,WP_OSTEOPONTIN_SIGNALING,11,Up,0.872547003053558,0.986566212530983
728,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.875492615791723,0.988536992006589
729,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Down,0.877339007658523,0.988896385732746
730,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Up,0.878386533427085,0.988896385732746
731,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.880851802672509,0.988896385732746
732,WP_NRF2ARE_REGULATION,20,Down,0.88123821221744,0.988896385732746
733,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.882944317004762,0.988896385732746
734,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.883029132758924,0.988896385732746
735,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.888512621276493,0.991793172793257
736,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Up,0.889153822536466,0.991793172793257
737,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.892031387252713,0.991793172793257
738,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Up,0.892359341559743,0.991793172793257
739,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.895168475043827,0.991793172793257
740,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.896400440482719,0.991793172793257
741,WP_MATRIX_METALLOPROTEINASES,8,Down,0.896549090261229,0.991793172793257
742,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.8977449906277,0.991793172793257
743,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Up,0.897836299317208,0.991793172793257
744,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.897901167804625,0.991793172793257
745,WP_PDGFRBETA_PATHWAY,27,Down,0.901833804464214,0.991793172793257
746,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.904879225627361,0.991793172793257
747,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Down,0.906697864887768,0.991793172793257
748,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.908548849051495,0.991793172793257
749,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.91044839432906,0.991793172793257
750,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.910464662144897,0.991793172793257
751,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.911573681016618,0.991793172793257
752,WP_DNA_MISMATCH_REPAIR,21,Up,0.913257570566191,0.991793172793257
753,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Down,0.913585793593298,0.991793172793257
754,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.915759576734102,0.991793172793257
755,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.915759576734102,0.991793172793257
756,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.916065508090389,0.991793172793257
757,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.916236760885303,0.991793172793257
758,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.918544205913316,0.991793172793257
759,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.920467870881892,0.991793172793257
760,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.920782070046678,0.991793172793257
761,WP_LUNG_PATHOLOGY_OF_COVID19,13,Up,0.921716737556762,0.991793172793257
762,WP_IL2_SIGNALING,37,Up,0.92177404367726,0.991793172793257
763,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.922491173579193,0.991793172793257
764,WP_HYPERTROPHY_MODEL,12,Up,0.923164335529939,0.991793172793257
765,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.92343484076742,0.991793172793257
766,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.925076415497443,0.991793172793257
767,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.929006963363192,0.991793172793257
768,WP_POSTCOVID_NEUROINFLAMMATION,11,Up,0.930704918609252,0.991793172793257
769,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.932307773914328,0.991793172793257
770,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.933475140496537,0.991793172793257
771,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Up,0.935041050609067,0.991793172793257
772,WP_KREBS_CYCLE_DISORDERS,11,Down,0.935125908121723,0.991793172793257
773,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.935227742715763,0.991793172793257
774,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.936789594245329,0.991793172793257
775,WP_ENDOMETRIAL_CANCER,49,Up,0.937125967530554,0.991793172793257
776,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.937633040104482,0.991793172793257
777,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.94013513422643,0.991793172793257
778,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.940206548118619,0.991793172793257
779,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.941879538543729,0.991793172793257
780,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.945835206744506,0.991793172793257
781,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.946997325506651,0.991793172793257
782,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.948109860410708,0.991793172793257
783,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.948109860410708,0.991793172793257
784,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.948359404465178,0.991793172793257
785,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.948733153768411,0.991793172793257
786,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,59,Down,0.949050612754512,0.991793172793257
787,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.949563536482109,0.991793172793257
788,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.951236097433089,0.992279279302029
789,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,88,Down,0.952624214196457,0.992467812508857
790,WP_ATM_SIGNALING,34,Up,0.954604331637014,0.992532458874984
791,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.955101186095027,0.992532458874984
792,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.95741457791069,0.993204204092956
793,WP_PI3KAKT_SIGNALING,173,Up,0.958164153096976,0.993204204092956
794,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Up,0.962240550125287,0.99499691162216
795,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.965053928825728,0.99499691162216
796,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.966379869694752,0.99499691162216
797,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Up,0.966445000125361,0.99499691162216
798,WP_HISTONE_MODIFICATIONS,36,Down,0.967936990609989,0.99499691162216
799,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.968311864021202,0.99499691162216
800,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.968366823963173,0.99499691162216
801,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.970935942572165,0.996391192002896
802,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.973357481176398,0.997630735071071
803,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,77,Up,0.975202609512636,0.997895091237691
804,WP_KIT_RECEPTOR_SIGNALING,50,Down,0.97934383484319,0.997895091237691
805,WP_TAR_SYNDROME,43,Down,0.98198567283186,0.997895091237691
806,WP_CILIARY_LANDSCAPE,183,Up,0.982656646101811,0.997895091237691
807,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Down,0.983274439151307,0.997895091237691
808,WP_GLYOXYLATE_METABOLISM,5,Up,0.983458849883337,0.997895091237691
809,WP_GLUTATHIONE_METABOLISM,10,Up,0.984502483781706,0.997895091237691
810,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,60,Up,0.986712197759021,0.997895091237691
811,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Down,0.98748237064042,0.997895091237691
812,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.987839982275937,0.997895091237691
813,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Down,0.98855560409752,0.997895091237691
814,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.988918659651388,0.997895091237691
815,WP_MRNA_PROCESSING,124,Up,0.989397201166324,0.997895091237691
816,WP_MACROPHAGE_MARKERS,8,Down,0.993053846190008,0.998914908393887
817,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.996753712527652,0.998914908393887
818,WP_ACUTE_MYELOID_LEUKEMIA,55,Down,0.997499234075223,0.998914908393887
819,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.997842012024552,0.998914908393887
820,WP_IL19_SIGNALING,20,Down,0.998676416105677,0.998914908393887
821,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.998694295943267,0.998914908393887
822,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.998914908393887,0.998914908393887
